Understanding Ketamine's Dissociative Effects (KD Study)

Recruiting Phase 1 Interventional Study
Epilepsy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Basic Science
Participants needed
20 (estimated)
Sponsor
Stanford University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient in Stanford Epilepsy Monitoring Unit * Age \>18 years old. Exclusion Criteria: * Lifetime psychotic or bipolar disorder * Inability to speak, read or understand English * Pregnant or nursing females * Prior adverse ketamine response
Contacts

Arjay Cordero

650-580-9000

arjayc@stanford.edu

CONTACT